It potently radiosensitizes colorectal cancer cells irrespective of functional p53 or Bax in vitro and shows encouraging anti-tumor efficacy accompanied by very little hepatotoxicity in combination with radiotherapy in vivo. Here, TP53 is linked to neoplasm.